［1］Calabrese LH, Furlan AJ, Gragg LA, Ropos TJ. Primary angiitis of the central nervous system: diagnostic criteria and clinical approach［J］. Cleve Clin J Med, 1992, 59(3):293-306.
［2］ Ropper AH, Ayata C, Adelman L. Vasculitis of the spinal cord［J］. Arch Neurol, 2003, 60(12):1791-1794.
［3］Hassan AS, Trobe JD, McKeever PE, Gebarski SS. Linear magnetic resonance enhancement and optic neuropathy in primary angiitis of the central nervous system［J］. J Neuroophthalmol, 2003, 23(2):127-131.
［4］Lanthier S, Lortie A, Michaud J, Laxer R, Jay V, deVeber G. Isolated angiitis of the CNS in children［J］. Neurology, 2001, 56(7):837-842.
［5］Benseler SM, deVeber G, Hawkins C, Schneider R, Tyrrell PN, Aviv RI, et al. Angiography-negative primary central nervous system vasculitis in children: a newly recognized inflammatory central nervous system disease［J］. Arthritis Rheum, 2005, 52(7):2159-2167.
［6］Vollmer TL, Guarnaccia J, Harrington W, Pacia SV, Petroff OA. Idiopathic granulomatous angiitis of the central nervous system: diagnostic challenges［J］. Arch Neurol, 1993, 50(9):925-930.
［7］Benseler SM, Silverman E, Aviv RI, Schneider R, Armstrong D, Tyrrell PN, et al. Primary central nervous system vasculitis in children［J］. Arthritis Rheum, 2006, 54(4):1291-1297.
［8］Aviv RI, Benseler SM, DeVeber G, Silverman ED, Tyrrell PN, Tsang LM, et al. Angiography of primary central nervous system angiitis of childhood: conventional angiography versus magnetic resonance angiography at presentation［J］. AJNR Am J Neuroradiol, 2007, 28(1):9-15.
［9］Abdel-Nasser AM, Ghaleb RM, Mahmoud JA, Khairy W, Mahmoud RM. Association of antiribosomal P protein antibodies with neuropsychiatric and other manifestations of systemic lupus erythematosus［J］. Clin Rheumatol, 2008, 27(11):1377-1385.
［11］Moritani T, Shrier DA, Numaguchi Y, Takahashi C, Yano T, Nakai K, et al. Diffusion-weighted echo-planar MR imaging of CNS involvement in systemic lupus erythematosus［J］. Acad Radiol, 2001, 8(8):741-753.
［12］Steens SC, Bosma GP, ten Cate R, Doornbos J, Kros JM, Laan LA, et al. A neuroimaging follow up study of a patient with juvenile central nervous system systemic lupus erythematosus［J］. Ann Rheum Dis, 2003, 62(6):583-586.
［13］Chang CJ, Chang WN, Huang LT, Chang YC, Huang SC, Hung PL, et al. Cerebral infarction in perinatal and childhood bacterial meningitis［J］. QJM, 2003, 96(10):755-762.
［14］Rodriguez-Pla A, Stone JH. Vasculitis and systemic infections［J］. Curr Opin Rheumatol, 2006, 18(1):39-47.
［15］Wang JJ, Jiang LQ, He B, Shi KL, Li JW, Zou LP. The association of CTLA-4 and CD28 gene polymorphisms with idiopathic ischemic stroke in the paediatric population［J］. Int J Immunogenet, 2009, 36(2):113-118.
［16］Shi KL, He B, Wang JJ, Zou LP. Role of TNF-alpha gene variation in idiopathic childhood ischemic stroke: a case-control study［J］. J Child Neurol, 2009, 24(1):25-29.
［17］Zou LP, Guo YH, Fang F, Jin H, Wu HS, Mix E. Evidence for human leukocyte antigen-related susceptibility in idiopathic childhood ischemic stroke［J］. Eur Neurol, 2002, 48(3):153-157.
［18］Amlie-Lefond C, Jubelt B. Neurologic manifestations of varicella zoster virus infections［J］. Curr Neurol Neurosci Rep, 2009, 9(6):430-434.
［19］Braun KP, Bulder MM, Chabrier S, Kirkham FJ, Uiterwaal CS, Tardieu M, et al. The course and outcome of unilateral intracranial arteriopathy in 79 children with ischaemic stroke［J］. Brain, 2009, 132(2):544-557.
［20］Nagel MA, Cohrs RJ, Mahalingam R, Wellish MC, Forghani B, Schiller A, et al. The varicella zoster virus vasculopathies: clinical, CSF, imaging, and virologic features［J］. Neurology, 2008, 70(11):853-860.
［21］Berger TM, Caduff JH, Gebbers JO. Fatal varicella-zoster virus antigenpositive giant cell arteritis of the central nervous system［J］. Pediatr Infect Dis J, 2000, 19(7):653-656.
［22］Lanthier S, Armstrong D, Domi T, deVeber G. Post-varicella arteriopathy of childhood: natural history of vascular stenosis［J］. Neurology, 2005, 64(4):660-663.
［24］Kocer B, Engur S, Ak F, Yilmaz M. Serum vitamin B12, folate, and homocysteine levels and their association with clinical and electrophysiological parameters in multiple sclerosis［J］. J Clin Neurosci, 2009, 16(3):399-403.
［25］Schlaug G, Siewert B, Benfield A, Edelman RR, Warach S. Time course of the apparent diffusion coefficient (ADC) abnormality in human stroke［J］. Neurology, 1997, 49(1):113-119.
［26］Vilela P, Goulao A. Cervical and intracranial arterial dissection: review of the acute clinical presentation and imaging of 48 cases［J］. Acta Med Port, 2003, 16(3):155-164.
［27］Rafay MF, Armstrong D, Deveber G, Domi T, Chan A, MacGregor DL. Craniocervical arterial dissection in children: clinical and radiographic presentation and outcome［J］. J Child Neurol, 2006, 21(1):8-16.
［28］Del-Rio Camacho G, Orozco AL, Perez-Higueras A, Camino Lopez M, Al-Assir I, Ruiz-Moreno M. Moyamoya disease and sagittal sinus thrombosis in a child with Down's syndrome［J］. Pediatr Radiol, 2001, 31(2):125-128.
［29］Rosser TL, Vezina G, Packer RJ. Cerebrovascular abnormalities in a population of children with neurofibromatosis type 1［J］. Neurology, 2005, 64(3):553-555.
［30］Dobson SR, Holden KR, Nietert PJ, Cure JK, Laver JH, Disco D, et al. Moyamoya syndrome in childhood sickle cell disease: a predictive factor for recurrent cerebrovascular events. Blood, 2002, 99(9):3144-3150.
［31］Czartoski T, Hallam D, Lacy JM, Chun MR, Becker K. Postinfectious vasculopathy with evolution to moyamoya syndrome［J］. J Neurol Neurosurg Psychiatry, 2005, 76(2):256-259.
［32］Kim SK, Yoo JI, Cho BK, Hong SJ, Kim YK, Moon JA. Elevation of CRABP-I in the cerebrospinal fluid of patients with Moyamoya disease［J］. Stroke, 2003, 34(12):2835-2841.
［33］Hillery CA, Panepinto JA. Pathophysiology of stroke in sickle cell disease［J］. Microcirculation, 2004, 11(2):195-208.
［34］Steen RG, Emudianughe T, Hankins GM, Wynn LW, Wang WC, Xiong X. Brain imaging findings in pediatric patients with sickle cell disease［J］. Radiology, 2003, 228(1):216-225.
［35］Ozdil M, Baris S, Ozyilmaz I, Dogru O, Celkan T, Albayram S. A rare cause of ischemic stroke: fibromuscular dysplasia［J］. Neurol Sci, 2009, 30(1):77-79.
